home / stock / csbr / csbr quote
Last: | $5.14 |
---|---|
Change Percent: | -5.76% |
Open: | $5.14 |
Close: | $5.14 |
High: | $5.14 |
Low: | $5.14 |
Volume: | 1,158 |
Last Trade Date Time: | 07/17/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$5.14 | $5.14 | $5.14 | $5.14 | $5.14 | 1,158 | 07-17-2024 |
$4.86 | $4.88 | $4.86 | $4.88 | $4.86 | 728 | 07-16-2024 |
$5.01 | $4.89 | $5.01 | $5.03 | $4.89 | 3,590 | 07-15-2024 |
$5.06 | $4.9862 | $5.06 | $5.09 | $4.86 | 2,013 | 07-12-2024 |
$5 | $5.055 | $5 | $5.09 | $5 | 1,653 | 07-11-2024 |
$5.14 | $5.12 | $5.14 | $5.15 | $5 | 1,878 | 07-10-2024 |
$5.01 | $5.01 | $5.01 | $5.12 | $4.88 | 1,831 | 07-09-2024 |
$5.02 | $4.92 | $5.02 | $5.02 | $4.92 | 1,313 | 07-08-2024 |
$5.05 | $4.85 | $5.05 | $5.05 | $4.85 | 6,101 | 07-05-2024 |
$4.85 | $4.86 | $4.85 | $4.86 | $4.85 | 730 | 07-04-2024 |
$4.85 | $4.86 | $4.85 | $4.86 | $4.85 | 730 | 07-03-2024 |
$4.86 | $4.99 | $4.86 | $4.99 | $4.86 | 2,324 | 07-02-2024 |
$4.95 | $4.95 | $4.95 | $5 | $4.95 | 2,210 | 07-01-2024 |
$5.17 | $5.07 | $5.17 | $5.18 | $4.95 | 4,285 | 06-28-2024 |
$5.05 | $5.13 | $5.05 | $5.17 | $4.9418 | 2,182 | 06-27-2024 |
$4.96 | $5.14 | $4.96 | $5.1454 | $4.94 | 1,035 | 06-26-2024 |
$4.94 | $0 | $4.94 | $0 | $0 | 26 | 06-25-2024 |
$4.94 | $4.95 | $4.94 | $5.18 | $4.93 | 7,491 | 06-24-2024 |
$5 | $4.86 | $5 | $5 | $4.76 | 5,018 | 06-21-2024 |
$4.83 | $4.83 | $4.83 | $4.83 | $4.83 | 810 | 06-20-2024 |
News, Short Squeeze, Breakout and More Instantly...
Champions Oncology Inc. Company Name:
CSBR Stock Symbol:
NASDAQ Market:
Champions Oncology Inc. Website:
CBL International Limited (BANL) is expected to report for quarter end 2024-03-31 Hilltop Holdings Inc. (HTH) is expected to report $0.24 for Q2 2024 Avidbank Holdings Inc (AVBH) is expected to report $0.68 for Q2 2024 Community West Bancshares (New) Com (CWBC) is expected to report $...
HACKENSACK, NJ / ACCESSWIRE / July 11, 2024 / Champions Oncology, Inc. (NASDAQ:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, will report its financial and operational results for the fourth quarter and year-ended April 30, 2024, on...
HACKENSACK, NJ / ACCESSWIRE / June 4, 2024 / Champions Oncology, Inc. (Nasdaq:CSBR), a leader in the development of advanced preclinical oncology solutions, has announced a strategic partnership with Medicines Discovery Catapult (MDC), enhancing their combined capabilities in the expanding f...